Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study

Abstract

BACKGROUND Postprandial elevation of triglyceride-rich lipoproteins impairs endothelial function, which can initiate atherosclerosis. We investigated the effects of bezafibrate on postprandial endothelial dysfunction and lipid profiles in patients with metabolic syndrome. METHODS Ten patients with metabolic syndrome were treated with 400 mg/day… (More)
DOI: 10.1186/1475-2840-13-71

Topics

7 Figures and Tables

Cite this paper

@inproceedings{Ohno2014BezafibrateIP, title={Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study}, author={Yuko Ohno and Toru Miyoshi and Yoko Noda and Hiroki Oe and Norihisa Toh and Kazufumi Nakamura and Kunihisa Kohno and Hiroshi Morita and Hiroshi Ito}, booktitle={Cardiovascular diabetology}, year={2014} }